Health Catalyst, a leading healthcare technology company, recently reported its fourth-quarter (Q4) and full-year 2025 ...
StockStory.org on MSN
Health Catalyst (NASDAQ:HCAT) posts better-than-expected sales in Q4 CY2025 but stock drops 10.4%
Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) announced in Q4 CY2025, but sales fell by 6.2% year on year ...
Analysts' ratings for Health Catalyst HCAT over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below provides a concise overview of recent ratings by analysts, ...
SALT LAKE CITY, Nov. 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. (HCAT) ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...
SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations ...
Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Health Catalyst (NASDAQ:HCAT) in the last three months. The following table encapsulates their ...
Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY, Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a ...
For a detailed discussion of the risk factors that could affect Health Catalyst's actual results, please refer to the risk factors identified in Health Catalyst's SEC reports, including, but not ...
UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™
SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. The latest update trims Health Catalyst's target from US$3.25 to US$2.75, while the modelled ...
In the last three months, 8 analysts have published ratings on Health Catalyst (NASDAQ:HCAT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results